Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Metformin for aging and cancer prevention.

Anisimov VN.

Aging (Albany NY). 2010 Nov;2(11):760-74. Review.

2.

The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer.

Anisimov VN, Bartke A.

Crit Rev Oncol Hematol. 2013 Sep;87(3):201-23. doi: 10.1016/j.critrevonc.2013.01.005. Epub 2013 Feb 21. Review.

3.

Metformin: do we finally have an anti-aging drug?

Anisimov VN.

Cell Cycle. 2013 Nov 15;12(22):3483-9. doi: 10.4161/cc.26928. Epub 2013 Oct 24. Review.

4.
5.

[Role of the growth hormone-insulin-like growth factor-1-insulin system signaling in aging and longevity: evolutional aspect].

Anisimov VN.

Ross Fiziol Zh Im I M Sechenova. 2008 Sep;94(9):1092-109. Review. Russian.

PMID:
18953996
6.

Conservative growth hormone/IGF-1 and mTOR signaling pathways as a target for aging and cancer prevention: do we really have an antiaging drug?

Anisimov VN.

Interdiscip Top Gerontol. 2015;40:177-88. doi: 10.1159/000364982. Epub 2014 Oct 13. Review.

PMID:
25341521
7.

Metformin as a geroprotector.

Bulterijs S.

Rejuvenation Res. 2011 Oct;14(5):469-82. doi: 10.1089/rej.2011.1153. Epub 2011 Sep 1. Review.

PMID:
21882902
8.

Life span extension and cancer risk: myths and reality.

Anisimov VN.

Exp Gerontol. 2001 Jul;36(7):1101-36. Review.

PMID:
11404054
9.

Caloric restriction in primates and relevance to humans.

Roth GS, Ingram DK, Lane MA.

Ann N Y Acad Sci. 2001 Apr;928:305-15. Review.

PMID:
11795522
10.

Caloric restriction.

Speakman JR, Mitchell SE.

Mol Aspects Med. 2011 Jun;32(3):159-221. doi: 10.1016/j.mam.2011.07.001. Epub 2011 Aug 10. Review.

PMID:
21840335
11.

Insulin-like growth factor 1 (IGF-1) and aging: controversies and new insights.

Bartke A, Chandrashekar V, Dominici F, Turyn D, Kinney B, Steger R, Kopchick JJ.

Biogerontology. 2003;4(1):1-8. Review.

PMID:
12652183
12.

Metformin in obesity, cancer and aging: addressing controversies.

Berstein LM.

Aging (Albany NY). 2012 May;4(5):320-9. Review.

13.

Diabetes, cancer, and metformin: connections of metabolism and cell proliferation.

Gallagher EJ, LeRoith D.

Ann N Y Acad Sci. 2011 Dec;1243:54-68. doi: 10.1111/j.1749-6632.2011.06285.x. Review.

PMID:
22211893
14.

Life span extension by resveratrol, rapamycin, and metformin: The promise of dietary restriction mimetics for an healthy aging.

Mouchiroud L, Molin L, Dallière N, Solari F.

Biofactors. 2010 Sep-Oct;36(5):377-82. doi: 10.1002/biof.127. Review.

PMID:
20848587
15.

Metformin and cancer.

Rizos CV, Elisaf MS.

Eur J Pharmacol. 2013 Apr 5;705(1-3):96-108. doi: 10.1016/j.ejphar.2013.02.038. Epub 2013 Mar 13. Review.

PMID:
23499688
16.

Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects.

Pierotti MA, Berrino F, Gariboldi M, Melani C, Mogavero A, Negri T, Pasanisi P, Pilotti S.

Oncogene. 2013 Mar 21;32(12):1475-87. doi: 10.1038/onc.2012.181. Epub 2012 Jun 4. Review.

PMID:
22665053
17.

Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans.

Barbieri M, Bonafè M, Franceschi C, Paolisso G.

Am J Physiol Endocrinol Metab. 2003 Nov;285(5):E1064-71. Review.

18.

Metformin and other biguanides in oncology: advancing the research agenda.

Pollak M.

Cancer Prev Res (Phila). 2010 Sep;3(9):1060-5. doi: 10.1158/1940-6207.CAPR-10-0175. Epub 2010 Sep 1. Review.

19.

Metformin: risk-benefit profile with a focus on cancer.

Provinciali N, Lazzeroni M, Cazzaniga M, Gorlero F, Dunn BK, DeCensi A.

Expert Opin Drug Saf. 2015 Oct;14(10):1573-85. doi: 10.1517/14740338.2015.1084289. Epub 2015 Sep 11. Review.

PMID:
26359221
20.

Genetics and pharmacology of longevity: the road to therapeutics for healthy aging.

Castillo-Quan JI, Kinghorn KJ, Bjedov I.

Adv Genet. 2015;90:1-101. doi: 10.1016/bs.adgen.2015.06.002. Epub 2015 Jul 29. Review.

PMID:
26296933

Supplemental Content

Support Center